DNAstack

www.dnastack.com
Innovation Type:
Informatics & AI
Cancer Type:
Multiple
Funding Stage:
Seed
Fund:
Compass Rose, Prospects
Development of a cloud platform for genomics data management, analysis and sharing

Related news

FACIT Features: DNAstack to lead and develop COVID Cloud for Canada’s Digital Technology Supercluster

December 1, 2020 – FACIT is pleased to accept the invitation to join the national consortium as Lead Commercialization Advisor. Read More

FACIT Makes Follow-on Investment in AI-based genomics company, DNAstack

FACIT's Compass Rose Oncology Fund is providing the follow-on investment. DNAstack also previously received capital from FACIT's early-stage Prospects Oncology Fund, illustrating FACIT's strategy to ensure promising companies grow roots and scale up in Ontario. Read More

FACIT Announces Investment in 3 Ontario Start-ups Under Prospects Fund

Ontario start-ups Radialis Medical of Thunder Bay, KA Imaging of Kitchener, and DNAstack of Toronto are the first to receive capital from FACIT's new Prospects Oncology Fund for proof-of-concept development of breakthrough cancer technologies. Read More

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.